WOODCLIFF LAKE, NJ
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE DESMOID TUMOR RESEARCH FOUNDATION, founded in 2005, is a small nonprofit in the Medical Research sector that reported $793K in total revenue in fiscal year 2024. Revenue surged 138% from the prior year, signaling strong growth momentum. The organization ran a surplus of $202K, a strong 25% operating margin.
THE ORGANIZATION RAISES FUNDS TO SUPPORT MEDICAL RESEARCH FOR DESMOID TUMORS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $792,998 | $333,727 | +1.4% |
| Expenses | $590,934 | $707,649 | -0.2% |
| Net Income | $202,064 | $-373,922 | -1.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BARARA ANN SELLINGER | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| STEVE WHITING | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| NICOLE DEICHERT | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| MARIA CROCITTO | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JERROLD MARCH | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| RACHEL SITTA | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| MARLENE PORTNOY | CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JEANNE WHITING | PRESIDENT/FORMER EXECUTIVE DIRECT | 20.00 |
Officer
Director
|
$6,875 | $0 | $6,875 |
| TOM ALLEN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| DJ CONNER | TREASURER | 4.00 |
Director
|
$0 | $0 | $0 |
| YATING WONG | DIRECTOR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| LYNNE HERNANDEZ | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$95,000 | $0 | $95,000 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $792,998 | $590,934 | $1,277,054 | $202,064 |
| 2023 | $333,727 | $707,649 | $1,034,489 | $-373,922 |
| 2022 | $993,749 | $712,927 | $1,439,427 | $280,822 |
| 2021 | $710,377 | $705,016 | $1,128,637 | $5,361 |
| 2020 | $548,284 | $471,645 | $1,161,128 | $76,639 |
| 2019 | $718,276 | $589,894 | $1,054,967 | $128,382 |
| 2018 | $714,396 | $616,174 | $921,341 | $98,222 |
| 2017 | $558,443 | $683,155 | $824,690 | $-124,712 |
Compare THE DESMOID TUMOR RESEARCH FOUNDATION with other nonprofits in New Jersey and across the country.